"On/off"-switchable crosslinked PTX-nanoformulation with improved precise delivery for NSCLC brain metastases and restrained adverse reaction over nab-PTX.
Li S, Meng C, Hao Q, Zhou R, Dai L, Guo Y, Zhao S, Zhou X, Lou C, Xu J, Xu P, Yang J, Ding Y, Lv Y, Han S, Li S, Li J, Kang H, Xiao Z, Tan M, Ma X, Wu H.
Li S, et al. Among authors: meng c.
Biomaterials. 2024 Jun;307:122537. doi: 10.1016/j.biomaterials.2024.122537. Epub 2024 Mar 14.
Biomaterials. 2024.
PMID: 38492523
Review.